Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-22-000617
Filing Date
2022-10-11
Accepted
2022-10-11 07:19:19
Documents
40
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sybleu093022form10q.htm   iXBRL 10-Q 400967
7 EXHIBIT 31.1 ex31_1.htm EX-31.1 8145
8 EXHIBIT 31.2 ex31_2.htm EX-31.2 10099
9 EXHIBIT 32.1 ex32_1.htm EX-32.1 4791
10 EXHIBIT 32.2 ex32_2.htm EX-32.2 4817
  Complete submission text file 0001607062-22-000617.txt   1781801

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cik0001818674-20220930.xsd EX-101.SCH 16876
3 XBRL CALCULATION FILE cik0001818674-20220930_cal.xml EX-101.CAL 32376
4 XBRL DEFINITION FILE cik0001818674-20220930_def.xml EX-101.DEF 33014
5 XBRL LABEL FILE cik0001818674-20220930_lab.xml EX-101.LAB 135964
6 XBRL PRESENTATION FILE cik0001818674-20220930_pre.xml EX-101.PRE 107011
34 EXTRACTED XBRL INSTANCE DOCUMENT sybleu093022form10q_htm.xml XML 125778
Mailing Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001
Business Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001 6192279192
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-248059 | Film No.: 221302319
SIC: 2834 Pharmaceutical Preparations